August 13, 2020

COVID-19 and Mental Health

Interview with Betty Pfefferbaum, MD, JD by Tom Linden, MD

Listen to Tom Linden, MD, Professor of Medical Journalism, University of North Carolina, Chapel Hill, interview Betty Pfefferbaum, MD, JD, George Lynn Cross Research Professor Emeritus, Department of Psychiatry and Behavioral Sciences, University of Oklahoma College of Medicine, Director, Terrorism and Disaster Center, Oklahoma City, OK, regarding her perspective piece on COVID-19 in the New England Journal of Medicine (NEJM). In this approximately 18-minute interview, Dr. Pfefferbaum discusses a wide range of mental health and public health topics as they relate to the COVID-19 pandemic, with a particular focus on the impact on healthcare professionals.

Other topics include:

  • COVID-19 in the outpatient setting
  • Self-proning in awake, non-intubated hospitalized patients
  • Managing personal and team stress during the COVID pandemic
  • ACE inhibitors and ARBs outcomes in patients with COVID-19
  • Hypertension medications and COVID risk
  • Non-peer reviewed studies during the COVID pandemic

This content also offers the opportunity to earn CME credits as part of NEJM Journal Watch.


COVID-19 and Mental Health

Betty Pfefferbaum, MD, JD, George Lynn Cross Research Professor Emeritus, Department of Psychiatry and Behavioral Sciences University of Oklahoma College of Medicine, Director, Terrorism and Disaster Center, Oklahoma City, OK
Interviewer: Tom Linden, MD,
Glaxo Wellcome Distinguished Professor of Medical Journalism, Director, Residential MA Program University of North Carolina Hussman School of Journalism and Media, Durham

From Journal Watch and the New England Journal of Medicine (NEJM)

LISTEN TO MORE LECTURES:

COVID-19: Exploring the Behavior of SARS-CoV-2 ⟶

Targetable Biological Mechanisms Implicated in Emergent Psychiatric Conditions Associated with SARS-CoV-2 Infection ⟶

Geriatric Patients And COVID-19 ⟶

COVID-19 in Children ⟶

COVID-19 and Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) ⟶

Circulation on the Run: Special COVID-19 Edition⟶

Post-Viral Olfactory Loss (PVOL): Insights in the
Age of the COVID-19 Pandemic ⟶

Facing COVID-19: Lessons Learned from Italy ⟶

The WHIP COVID-19 Study: The Use of Hydroxychloroquine as Prophylaxis for COVID-19 ⟶

Coding in the World of COVID-19: Non-Face-to-Face Evaluation and Management Care ⟶

COVID-19 and Anxiety: Actionable Tools for the Care Team ⟶

What is Coronavirus Disease (COVID-19) and What Doctors Need to Know ⟶


 


For more Coronavirus Resources & Tools from UpToDate and Ovid




ADDITIONAL RESOURCES:

The World Health Organization (WHO) ⟶ 

WHO Daily Updates on Coronavirus (COVID-19) Outbreak ⟶


*This single lecture is not a CME activity.






View
Your
Offer

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.   Agree